Akero Therapeutics
AKRO
AKRO
54 hedge funds and large institutions have $288M invested in Akero Therapeutics in 2019 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
5.15% more ownership
Funds ownership: 39.46% → 44.62% (+5.2%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
54
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$27.9M | |
| 2 | +$9.74M | |
| 3 | +$7.38M | |
| 4 |
Alkeon Capital Management
New York
|
+$6.41M |
| 5 |
BlackRock
New York
|
+$3.68M |
Top Sellers
| 1 | -$4.02M | |
| 2 | -$2.87M | |
| 3 | -$2.14M | |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$2.11M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.46M |